http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-60239670-D1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47b86b2214c47fcc5a072d0f136926a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ebf622f4e9994097f13cff68b540d7a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
filingDate 2002-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6b091e936ffae360a65c80d0b04a7b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_505aa60391ff9701cdbf59f479fb5b04
publicationDate 2011-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-60239670-D1
titleOfInvention USE OF OXYTOCIN FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION AGAINST CARCINOMA IN SITU AND ZERVIZITIS
priorityDate 2001-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18429
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38288
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439302
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID352920
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4813803
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507320
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100152272
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5020

Total number of triples: 39.